1. Plasma alpha-L-fucosidase activity in chronic inflammation and autoimmune disorders in a pediatric cohort of hospitalized patients
   Ildikó Endreffy et al, 2017, Immunologic Research CrossRef
2. Serum α-l-fucosidase activities are significantly increased in patients with preeclampsia
   Meng Zhang et al, 2019, Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A CrossRef
3. CTCF-activated FUCA1 functions as a tumor suppressor by promoting autophagy flux and serum α-L-fucosidase serves as a potential biomarker for prognosis in ccRCC
   Shuo Zhao et al, 2024, Cancer Cell International CrossRef
4. Reduced expression of α-L-Fucosidase-1 (FUCA-1) predicts recurrence and shorter cancer specific survival in luminal B LN+ breast cancer patients
   Serena Bonin et al, 2018, Oncotarget CrossRef
5. Mechanism of Resveratrol Induced Apoptosis in Prostate Cancer Cells
   爱辉 许, 2020, Advances in Clinical Medicine CrossRef
6. Downregulation of α‐l‐fucosidase 1 suppresses glioma progression by enhancing autophagy and inhibiting macrophage infiltration
   Lixia Xu et al, 2020, Cancer Science CrossRef
7. Interference with KCNJ2 inhibits proliferation, migration and EMT progression of apillary thyroid carcinoma cells by upregulating GNG2 expression
   Siyuan Chen et al, 2021, Molecular Medicine Reports CrossRef
8. Genetics of enzymatic dysfunctions in metabolic disorders and cancer
   Mélanie Mahé et al, 2023, Frontiers in Oncology CrossRef
9. FUCA1: An Underexplored p53 Target Gene Linking Glycosylation and Cancer Progression
   Die Hu et al, 2024, Cancers CrossRef
10. Glycosylation in the Thyroid Gland: Vital Aspects of Glycoprotein Function in Thyrocyte Physiology and Thyroid Disorders
    Marta Ząbczyńska et al, 2018, International Journal of Molecular Sciences CrossRef